Bogart Wealth LLC’s Immunogen Inc IMGN Stock Holding History

Bogart Wealth LLC’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-50	Closed	–	–	1177
2022 Q2	$0	Buy	+50	New	+$217	﹤0.01%	1006

Other funds holding IMGN

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Bogart Wealth LLC's IMGN Position: Q3 2022 in Review

Bogart Wealth LLC sold out of Immunogen Inc (IMGN) in Q3 2022, closing a stake of 50 shares.

Bogart Wealth LLC first reported a position in IMGN in Q2 2022 and held it in 1 quarter. The position peaked at $0 in Q2 2022. 222 funds tracked by Wall St. Rank hold IMGN as of Q3 2022.

Bogart Wealth LLC reported no remaining Immunogen Inc position as of Q3 2022 after selling out during the quarter.
Bogart Wealth LLC sold 50 Immunogen Inc shares in Q3 2022.
Bogart Wealth LLC first reported a position in Immunogen Inc in Q2 2022 and held it in 1 quarter.
Bogart Wealth LLC's Immunogen Inc position peaked at $0 in Q2 2022.
222 funds tracked by Wall St. Rank held Immunogen Inc as of Q3 2022.

Based on Bogart Wealth LLC's 13F filing for Q3 2022, filed 3 Nov 2022.